Circulating miRNAs can be more effective than other biomarkers once their expression has not shown correlation with clinic-pathological features such as hormone receptors, HER expression, Ki67, lymph node status, tumor size or age [10] and they are stable molecules with low post transcriptional variations that are potentially individually related. The gene discussed is NR4A1; the disease is neoplasm.